| Hidradenitis suppurativa disproportionally affects women of childbearing age. |
| Safety and efficacy of the various available medical and procedural hidradenitis suppurativa treatments must be considered when developing an appropriate treatment plan for pregnant or breastfeeding patients with hidradenitis suppurativa. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.